KRAS, NRAS,BRAF mutation testing in Israel: Our Best Clinics and Costs 2025

Dr. Auala Hubert is a Medical Oncologist & Radiotherapist at Hadassah Medical Center, speaking English and Hebrew, with 33 years of experience and qualifications in Oncology and Radiotherapy. Medical Oncology & Radiotherapy Speciality Languages: English, Hebrew Graduated: 1990 (33 years since graduation) Education: Psychology, Hebrew University; M.D. Hadassah University Hospital, Jerusalem, Israel Professional Experience: Head of Gastrointestinal Cancer Center; Senior Physician, Oncology Dept., Hadassah University Hospital; Resident, Oncology Dept., Hadassah University Hospital; Intern, Hadassah University Hospital Certifications: Board Exam, Oncology Part I; USMLE Qualification Parts I & II; Board Exam., Oncology & Radiotherapy Part II Memberships: Israel Society of Clinical Oncology; Israel Medical Society; Israel Cancer Association; Committee for Gastrointestinal Cancer; Committee for Medical and Social Services

Known Expertise Medical Oncologist Academic Position Senior Lecturer EducationBar-Ilan University, Israel / Computational Biology Israeli Society for Health-Tech / Fellowship by IMA/ Innovation and Entrepreneurship in Medicine and Health-Tech Sheba Medical Center and Bar-Ilan University, Israel/ Genomics and Biomedical Informatics Semmelweis University/Doctor of Medicine Training and Specialization Clinical observership in acute oncology, early phase clinical trials and lung cancer/ Guy's and St. Thomas hospital, London, England Leader Shift, Executive Development Program, Tel-Aviv Sourasky Medical Center Fellowship Program in Innovation and Entrepreneurship in Medicine and Health-Tech Resident, Medical Oncology, TASMC, Israel 6th year medical school rotations, Kaplan Medical Center, Israel Rotation, intensive care unit and pulmonology, Stony Brook hospital, NY, US Clinical Experience Leader of the TASMC oncology project of PSIFAS, the Israeli National Genomic Medicine Initiative PI for study initiator trial: T-Cell Repertoire sequencing as clinical efficacy tool for pembrolizumab (with platinum based chemotherapy) in advanced NSCLC. PI for study initiator trial: T-cell repertoire sequencing as a clinically efficacy tool for neoadjuvant immunotherapy plus platinum-doublet chemotherapy for resectable NSCLC. Representative of the National Medical Association for the National Council for the Prevention, Diagnosis and Treatment of Malignant Diseases, as well as head of the oncology field, Leumit HMO Consultant on drugs and operations in the field of oncology, Leumit HMO Member of the Helsinki Committee for Clinical Studies, TASMC Primary investigator (PI) in pharmaceutical phases I&III clinical trials Head of oncology day-care service, TASMC, Israel Molecular Tumor Board (MTB) moderator of the Israeli Lung Cancer Society NGS interpretation clinic alongside head of pathology, TASMC, Israel PI for study initiator trial: Genomic Variant of BCL-2 as a Novel Predictor of Response to Paclitaxel, TASMC, Israel Medical oncology clinic in the field of lung and breast cancer, TASMC, IsraelLeading sub-investigator (SI) in many phase I-III clinical trials in oncology, including intra-tumoral injections (mRNA, viruses and NO), TASMC, Israel Courses Good Clinical Practice ICH GCP R2 & Israeli MOH Guidelines Updated Course Point-of-Care Ultrasound course, Israeli Medical Association GCP training Bioforum GCP training BioforumInvestigator Site Personnel ICH GCP Training Certificate - TransCelerate BioPharma Academic Experience Lecturer in the Department of Medical Education at the Faculty of Medical and Health Sciences at Tel Aviv University JIMS Journal Club - Instructor for students. Guidance of Dr. Aviv Berkovich M.D in basic science: cfDNA NGS for identification ofprimary and acquired resistance in patients with Lung Cancer and EGFR mutations. TASMC, Israel in collaboration with The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, NY USA Training team for oncology residents, TASMC, Israel Mentor for new intern, TASMC, Israel Tutor for medical students in oncology clerkships, Tel-Aviv University, Israel Honors Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel Sign of honor for reserve medical personnel for the battle in Lebanon, IDFCompletion of residency final examination (shlav Beit) with honors Israeli society for clinical oncology and radiation therapy (ISCORT) 17 research grant competition winner Affiliations Israeli Medical Association (IMA) Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT) The Israeli Lung Cancer Group (ILCG) European Society of Medical Oncology (ESMO) International Association for the Study of Lung Cancer (IASLC) The International Society of Liquid Biopsy (ISLB) The Israeli Society for Health-Tech Boards Co-founder, board member and treasurer of the Israeli Acute Oncology Society Clinical Research Association Board of Directors on behalf of the Israeli Lung Cancer Group Member of the Trustees of Oncology Innovation, TASMC, Israel Doctor of Medical Service IDF Areas of interest Thoracic malignancies, early to late phase clinical trials, intra-tumoral injections, comprehensive genomic profiling of tumors, liquid biopsies: cfDNA, TCR rep-seq and epi-Genetics; cell therapy